ICN2 Plasmonic Biosensor for COVID and other conditions

preview_player
Показать описание
An innovative nano-biosensor for fast, quantitative and accurate COVID-19 serology, which achieves the high reliability of specialised laboratory analysis with the short times and simplicity of rapid self-tests, has been developed by a team of researchers led by Prof. Laura M. Lechuga, head of the ICN2 NanoBiosensors and Bioanalytical Applications Group. This work has been developed in collaboration with the Vall d'Hebron University Hospital and Research Institute (VHIR, Barcelona) and the Hospital Clínic of Barcelona–IDIBAPS –which provided the clinical samples and the validation— and the Emerging Virus Unit of Aix-Marseille University (France).

Read more at:
Рекомендации по теме